One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study
Background: To evaluate the one-year immunogenicity and safety of a subunit plague vaccine. Methods: In the initial study, 240 healthy adults aged 18–55 years were administrated with 2 doses of 15 or 30 µg plague vaccines at day 0 and 28, respectively. In this extended follow-up study, we evaluated...
Main Authors: | Jialei Hu, Lei Jiao, Yuemei Hu, Kai Chu, Jingxin Li, Fengcai Zhu, Taishun Li, Zhiyuan Wu, Dong Wei, Fanyue Meng, Bingxiang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1486154 |
Similar Items
-
SOME WAYS OF PRODUCTION PROCESS OF LIVE PLAGUE VACCINE AND TECHNIQUES OF EVALUATION THE IMMUNOGENICITY (REVIEW)
by: Zh. A. Konovalova, et al.
Published: (2013-04-01) -
Immunogenicity and safety of a meningococcal serogroups A and C tetanus toxoid conjugate vaccine (MenAC-TT): two immune schedules in toddles aged 12–23 months in China
by: Jialei Hu, et al.
Published: (2019-12-01) -
The efficacy, safety, and immunogenicity of plague vaccines: A systematic literature review
by: Louise Hartley, et al.
Published: (2023-01-01) -
Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
by: Huayue Ye, et al.
Published: (2020-11-01) -
Comparative Analysis of the Immunogenic Activity of the Plague Vaccine Depending on the Growing Medium
by: S. E. Gostishcheva, et al.
Published: (2021-07-01)